AryoTrust

trastuzumab (biosimilar) · AryoGen Pharmed Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AryoTrust, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer [Phase 3]

See pricing